Advertisement

All Lots of Liptruzet in U.S. Recalled Over Packaging Defect — Physician’s First Watch

Medical News |
January 15, 2014

All Lots of Liptruzet in U.S. Recalled Over Packaging Defect

By Larry Husten

All lots of the combination cholesterol-lowering drug Liptruzet (ezetimibe and atorvastatin) in the U.S. are being recalled because a packaging defect could allow air and moisture to affect the quality of the drug, Merck announced on Tuesday.

The company noted that "the likelihood of the packaging defects decreasing the effectiveness of Liptruzet on a patient's lipid profile or negatively impacting the safety of the product is remote." To date, no adverse events or product complaints have been reported.

Merck is recalling the drug from U.S. wholesalers but is not asking patients or pharmacies to return their stock; patients may continue taking pills already in their possession.

Adapted with permission from CardioExchange.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement